Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
ADAR1 CAPITAL MANAGEMENT LLC | 05-15-2024 | 03-31-2024 | 261 | 440,787,751 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | COM | 1 | $63,627,590 | 425,745 | 0.01 | 425,745 | +Inf | 03-31-2024 | |
EA SERIES TRUST | ALPHA ARCH 1-3 | 2 | $33,867,055 | 318,120 | 0.01 | 318,120 | +Inf | 03-31-2024 | |
ROIVANT SCIENCES LTD | SHS | 3 | $29,426,310 | 2,791,870 | 0.01 | 2,791,870 | +Inf | 03-31-2024 | |
SPDR S&P 500 ETF TR | TR UNIT | 4 | $27,199,640 | 52,000 | 0.01 | 52,000 | +Inf | 03-31-2024 |